Skip to main content
SpringerLink
Log in

Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves

  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

The ultrastructure of bovine platelets was examined by transmission electron microscopy without any pretreatment (control), and after WEB 2086 (a triazolodiazepine) or ketoprofen (NSAID) pretreatment, followed by PAF infusion. The blood platelet count was also investigated. The group of calves that received WEB 2086 pretreatment before platelet-activating factor (PAF) infusion did not show a decreased number of platelets. However, in the other group, with ketoprofen pretreatment before PAF infusion, there was a rapid decrease from 1 to 3 min, while from 5 min the number of platelets recovered to the normal value. Electron microscopy revealed that pretreatment with WEB 2086 followed by PAF infusion did not alter the morphological ultrastructure of bovine platelets, except that the microtubules were briefly modified from 1 until 3 min after PAF challenge. After ketoprofen pretreatment, bovine platelets kept their regular shape, the number of dense bodies was not significantly altered, the number of mitochondria was maintained from 5 min after PAF infusion, giant platelets were not observed and the Golgi apparatus was rarely visible. Thus pretreatment with WEB 2086 and ketoprofen before PAF infusion had a protective activity on the ultrastructure of bovine platelets and, in cattle, pretreatment with WEB 2086 and ketoprofen before PAF challenge prevented the thrombocytopenia induced by PAF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Bastos da Silva, M., Herion, F., Raskinet, R., David, J.-L., Gustin, P., Dessy, C. and Lekeux, P., 1996. Inhibition of PAF-induced platelet aggregation by WEB 2086 “in vitro”, an antagonist to the receptor for platelet-activating factor, in bovine. Journal of Veterinary Medicine A, 43, 399-413.

    Google Scholar 

  • Bastos da Silva, M., Herion, F., Raskinet, R., David, J.-L., Gustin, P. and Lekeux, P., 1997a. Combined effect of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced ex-vivo platelet aggregation in bovine. Journal of Veterinary Medicine A, 44, 65-71.

    Google Scholar 

  • Bastos da Silva, M., Herion, F., Raskinet, R., David, J.-L., Gustin, P., Gougnard, T., Plompteux, G., Desmecht, D. and Lekeux, P., 1997b. Effect of intravenous administration of WEB 2086 on healthy Friesian calves.Veterinary Research Communications, 21, 521-531

    Google Scholar 

  • Bastos da Silva, M., Dessy, C. and Lekeux, P., 1997c. Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves. Veterinary Research, 28, 489-502

    Google Scholar 

  • Bastos da Silva, M., Gustin, P., Herion, F., David, J.-L., Raskinet, R., Van de Weerdt, M. and Lekeux, P., 1998. Effect of ketoprofen (NSAID) on PAF-induced bovine platelet aggregation. The Veterinary Journal, 155, 201-203

    Google Scholar 

  • Bondy, G.S. and Gentry, P.A., 1989. Characterization of the normal bovine platelet aggregation response. Comparative Biochemistry and Physiology, 92C, 67-72

    Google Scholar 

  • Braquet, P. and Rola-Preszczynski, M., 1987. Platelet-activating factor and cellular immune responses. Immunology Today, 8, 345-352

    Google Scholar 

  • Braquet, P., Touqui, L., Shen, T.Y. and Vargaftig, B.B., 1987. Perspectives in platelet-activating factor research. Pharmacological Reviews, 39, 97-145

    Google Scholar 

  • Brecht, H.M., Adamus, W.S., Heuer, H.O., Birke, F.W. and Kempe, E.R., 1991. Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man. Drug Research, 41, 51-59

    Google Scholar 

  • Brune, K., Geisslinger, G. and Menzel-Soglowek, S., 1992. Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. Journal of Clinical Pharmacology, 32, 944- 952

    Google Scholar 

  • Cargill, D.I., Cohen, D.S., Van Valen, R.G., Klinek, J.J. and Levin, R.P., 1989. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). Thrombosis Haemostasis, 49, 204-207

    Google Scholar 

  • Fairbairn, S.M., Marr, K.A., Lees, P. and Cunningham, F.M., 1996. Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease. Research in Veterinary Science, 61, 107-113

    Google Scholar 

  • Foster, A.P., Lees, P., Andrews, M.J. and Cunningham, F.M., 1992. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Equine Veterinary Journal, 24, 203-207

    Google Scholar 

  • Gentry, P.A., 1992. The mammalian blood platelet: its role in haemostasis, inflammation and tissue repair. Journal of Comparative Pathology, 107, 243-270

    Google Scholar 

  • Gentry, P.A., Tremblay, R.R. and Ross, M.L., 1989. Failure of aspirin to impair bovine platelet function. American Journal of Veterinary Research, 50, 919-922

    Google Scholar 

  • Grauert, A.M., 1974. Dehydration schedules. In: A.M. Glauert (ed.), Practical Methods in Electron Microscopy, volume 3, (American Elsevier, New York), 112-120

    Google Scholar 

  • Grouse, L.H., Rao, G.H., Weiss, D.J., Perman, V. and White, J.G., 1990. Surface-activated bovine platelets do not spread, they unfold. American Journal of Pathology, 136, 399-408

    Google Scholar 

  • Jain, N.C., 1993. The platelets. In: N.C. Jain (ed.), Essentials of Veterinary Hematology, (Lea and Febiger, Philadelphia), 105-132

    Google Scholar 

  • Landoni, M.F., Cunningham, F.M. and Lees, P., 1995. Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling. Journal of Veterinary Pharmacology and Therapeutics, 18, 315-324

    Google Scholar 

  • Lauri, D., Cerletti, C. and de Gaetano, G., 1985. Amplification of primary response of human platelets to platelet-activating factor. Aspirin-sensitive and aspirin-insensitive pathways. Journal of Laboratory and Clinical Medicine, 105, 653-658

    Google Scholar 

  • Lohman, I.C. and Halonen, M., 1990. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit. American Review of Respiratory Disease, 142, 390-397

    Google Scholar 

  • Martins, M.A., Martins, P.M.R.S., Faria Neto, H.C.C., Bozza, P.T., Dias, P.M.F.L., Cordeiro, R.S.B. and Vargaftig, B.B., 1988. Intravenous injections of PAF-acether induce platelet aggregation in rats. European Journal of Pharmacology, 149, 89-96

    Google Scholar 

  • Meyers, K.M., Katz, J.B., Clemmons, R.M., Smith, J.B. and Holmsen, H., 1980. An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink and man. Thrombosis Research, 20, 13-24

    Google Scholar 

  • Meyers, K.M., Hopkins, G., Holmsen, H.H., Benson, K. and Prieur, D.J., 1982. Ultrastructure of resting and activated storage pool deficient platelets from animals with the Che¨ diak-Higashi syndrome. American Journal of Pathology, 106, 364-377

    Google Scholar 

  • Pinckard, R.N., 1982. The `new' chemical mediators of inflammation. In: G. Majino, R.S. Cotran and N. Kaufman (eds), Current Topics in Inflammation and Infection, (Williams and Wilkins, Baltimore), 38-53

    Google Scholar 

  • Prescott, S.M., Stafforini, D.M., Zimmerman, G.A. and McIntyre, T.M., 1995. The natural history of PAF: from physiological regulator to pathological mediator. In: Proceedings 5th International Congress on Platelet-Activating Factor and Related Lipid Mediators, Berlin, p. 2

  • Pretolani, M., Lefort, J., Malanchere, E.. and Vargaftig, B.B., 1987. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea pigs. European Journal of Pharmacology, 140, 311-321

    Google Scholar 

  • Twomey, B. and Dale, M., 1992. Cyclooxygenase-independent effects of non-steroidal anti-inflammatory drugs on the neutrophil respiratory burst. Biochemical Pharmacology, 43, 413-418

    Google Scholar 

  • Vane, J.R., 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biology), 231, 232-235

    Google Scholar 

  • Veys, E.M. (ed.), 1991. 20 Years' Experience with Ketoprofen. (Scandinavian Journal of Rheumatology, 90), 44pp

  • Vieira, S., 1985. O test t. Análise de variância. In: Introdução a Bioestatística, 3rd edn, (Editora Campus Ltda, Rio de Janeiro, Brazil), 223-245

    Google Scholar 

  • Ware, J.A. and Coller, R.S., 1995. Platelet morphology, biochemistry and function. In: E. Beutler, M.A. Lichtman, B.S. Collier and T.J. Kipps (eds), WilliamsHematology, 5th edn, (McGraw-Hill, USA), 1149- 1201

    Google Scholar 

  • Weber, K. and Heuer, H.O., 1989. Hetrazepines as antagonists of platelet activating factor. Medicinal Research Reviews, 9, 181-218

    Google Scholar 

  • White, J.G., 1972. Interaction of membrane systems in blood platelets. American Journal of Pathology, 66,295

    Google Scholar 

  • White, J.G., 1987. The secretory pathway of bovine platelets. Blood, 69, 878-885

    Google Scholar 

  • White, J.G., 1994. Anatomy and structural organization of the platelet. In: R.W. Colman, J. Hirsh, V.J. Marder and E.W. Salzman (eds), Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn, (Lippincott, Philadelphia), 397-413

    Google Scholar 

  • Zucker-Franklin, D. Benson, K.A. and Meyers, K.M., 1985. Absence of a surface-connected canalicular system in bovine platelets. Blood, 65, 241-244

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Functional Investigation, Department of Physiology, Bât. B42, Faculty of Veterinary Medicine, University of Liege, Sart Tilman, B-4000, Liege, Belgium

    M. Bastos da Silva, J. Coghe & P. Lekeux

  2. Laboratory for Histology, University of Liege, Sart Tilman, Bât. B43, Faculty of Veterinary Medicine, B-4000, Liege, Belgium

    C. Dessy

  3. Thrombosis-Hematosis Unit, C.H.U., University of Liege, Sart Tilman, B-4000, Liege, Belgium

    J.-L. David

Authors
  1. M. Bastos da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Dessy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Coghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J.-L. David
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Lekeux
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bastos da Silva, M., Dessy, C., Coghe, J. et al. Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves. Vet Res Commun 22, 273–291 (1998). https://doi.org/10.1023/A:1006007802126

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006007802126

Search

Navigation